ACE2 and non-small cell lung carcinoma: ACE2 overexpression or ACE2-Ang-(1-7)- MasR activation may suppress angiogenesis either by inhibiting the production of VEGFa in NSCLC [43], or VEGF receptors attenuation in nasopharyngeal carcinoma [44], respectively.